WAS
IMNN icon

WESPAC Advisors SoCal’s Imunon IMNN Stock Holding History

WESPAC Advisors SoCal’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed – – 183
2019
Q1 		$0 Hold
1
– – ﹤0.01% 347
2018
Q4 		$0 Hold
1
– – ﹤0.01% 351
2018
Q3 		$0 Buy
+1
New +$551 ﹤0.01% 312
2018
Q2 		– Sell
-1
Closed – – 166
2018
Q1 		$0 Hold
1
– – ﹤0.01% 283
2017
Q4 		$0 Buy
+1
New +$567 ﹤0.01% 267

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
DA
Dillon & Associates Jackson, Michigan $726M AUM 18.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WESPAC Advisors SoCal's IMNN Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Imunon (IMNN) in Q2 2019, closing a stake of 1 share.

WESPAC Advisors SoCal first reported a position in IMNN in Q4 2017 and held it in 5 quarters. The position peaked at $0 in Q1 2019. 18 funds tracked by Wall St. Rank hold IMNN as of Q2 2019.

  • WESPAC Advisors SoCal reported no remaining Imunon position as of Q2 2019 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 1 Imunon share in Q2 2019.
  • WESPAC Advisors SoCal first reported a position in Imunon in Q4 2017 and held it in 5 quarters.
  • WESPAC Advisors SoCal's Imunon position peaked at $0 in Q1 2019.
  • 18 funds tracked by Wall St. Rank held Imunon as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.